(Q39688817)

14 September 2017

title

Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell (English)

1 reference

14 September 2017

0 references

Xian-Run Luo

1

1 reference

14 September 2017

Jian-Sheng Li

series ordinal

2

1 reference

14 September 2017

Ying Niu

series ordinal

3

1 reference

14 September 2017

Li Miao

series ordinal

4

1 reference

14 September 2017

language of work or name

1 reference

24 June 2010

1 reference

Molecular Biology Reports

14 September 2017

published in

1 reference

14 September 2017

volume

38

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

1201-1207

1 reference

Current management of gastric cancer

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Adenocarcinoma of the stomach: are we making progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Multidisciplinary approach to understand the pathogenesis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

GENE THERAPY FOR THE TREATMENT OF PITUITARY TUMORS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Adenoviral vector-based strategies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Combined suicide and cytokine gene therapy for peritoneal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Targeted therapy by disabling crossroad signaling networks: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

Targeted therapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0218-8

The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression

21 January 2018

1 reference

12 December 2020

In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer

1 reference

12 December 2020

Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation

1 reference

12 December 2020

Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions.

1 reference

12 December 2020

Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.

1 reference

12 December 2020

Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo.

1 reference

12 December 2020

Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer.

1 reference

12 December 2020

Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus

1 reference

12 December 2020

Cancer-specific gene therapy.

1 reference

12 December 2020

Gastric adenocarcinoma: review and considerations for future directions

1 reference

12 December 2020

Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment

1 reference

12 December 2020

Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase.

1 reference

12 December 2020

10.1007/S11033-010-0218-8

Identifiers

DOI

1 reference

14 September 2017

1 reference